Leflunomide for relapsing polychondritis: Successful longterm treatment [7]

Journal of Rheumatology

Volumn 33, Issue 9, 2006, Pages 1916-

  Handler, Richard P ^a  

^a Medical Associates of Saranac Lake   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; GLUCOCORTICOID; LEFLUNOMIDE; PREDNISOLONE;

AUTOIMMUNE DISEASE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MECHANISM; EAR CARTILAGE; EAR LOBE; HUMAN; LETTER; LONG TERM CARE; PRIORITY JOURNAL; RARE DISEASE; RELAPSING POLYCHONDRITIS; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS; C-REACTIVE PROTEIN; CHOLESTYRAMINE; CHOLESTYRAMINE RESIN; DRUG THERAPY, COMBINATION; FEVER; HUMANS; ISOXAZOLES; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MIDDLE AGED; PHOTOPHOBIA; PLATELET COUNT; POLYCHONDRITIS, RELAPSING; THROMBOCYTOSIS; TREATMENT FAILURE;

EID: 33748560816     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Koenig AS, Abruzzo JL. Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis. J Rheumatol 2002;29:192-4.